CD4 and lung carcinoma: As shown in Table 1, Fig 1, the proportion of CD4+CD25+FOXP3+/CD4+ T cells was significantly higher in the lung cancer patients than in their healthy counterparts by student’s t test (t = 7.16, P < 0.01).